(This June 23 story corrects second paragraph to show that the recommendation is to approve the relapsing forms, not the relapsing-remitting form of MS.)
FRANKFURT Germany’s Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis (MS)...
https://goo.gl/DQBALR
Sunday, 25 June 2017
Germany's Merck gets EU backing for oral MS drug | Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment